Results 301 to 310 of about 956,734 (410)

Low‐Irradiance Antimicrobial Blue Light‐Bathing Therapy for Wound Infection Control

open access: yesAdvanced Science, EarlyView.
Antimicrobial blue light has been shown as an appealing non‐pharmacological antimicrobial alternative. However, its clinical applications have been hindered by high irradiance‐associated photothermal risks. In this work, a low‐irradiance blue light‐bathing concept and a wearable photonic wound patch are established to address this challenge in terms of
Jie Hui   +12 more
wiley   +1 more source

RIGHT KIDNEYS AND DELAYED GRAFT FUNCTION: CLINICAL IMPLICATIONS.

open access: bronze, 2008
Henri Vacher-Coponat   +5 more
openalex   +1 more source

Osteoblast‐Derived Mitochondria Formulated with Cationic Liposome Guide Mesenchymal Stem Cells into Osteogenic Differentiation

open access: yesAdvanced Science, Volume 12, Issue 12, March 27, 2025.
This study demonstrates that the transfer of mitochondria from osteoblasts to mesenchymal stem cells (MSCs) enhances osteogenic differentiation. MSCs receiving osteoblast‐derived mitochondria exhibit increased expression of key osteogenic markers (Runt‐related transcription factor 2, RUNX2; Osterix, OSX; Osteopontin, OPN) and activate the BMP2 (Bone ...
Hye‐Ryoung Kim   +11 more
wiley   +1 more source

THE IMPACT OF DELAYED GRAFT FUNCTION ON ACTUAL GRAFT SURVIVAL IS EQUALLY BAD IN DECEASED DONOR KIDNEY TRANSPLANTS FROM EXPANDED CRITERIA DONORS AND STANDARD CRITERIA DONORS.

open access: bronze, 2008
Jean Tchervenkov   +6 more
openalex   +1 more source

Machine Learning‐Enhanced Optimization for High‐Throughput Precision in Cellular Droplet Bioprinting

open access: yesAdvanced Science, EarlyView.
A high‐throughput droplet‐based cellular bioprinting platform enhanced with machine learning optimizes five key printing parameters—bioink viscosity, nozzle size, printing time, printing pressure, and cell concentration—to enable accurate prediction of droplet size.
Jaemyung Shin   +7 more
wiley   +1 more source

SERUM TISSUE INHIBITOR OF ETALLOPROTEINASES 1 (TIMP-1) AS A PREDICTOR OF ORGAN RECOVERY FROM DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION FROM DONORS AFTER CARDIAC DEATH

open access: bronze, 2008
Mamoru Kusaka   +9 more
openalex   +1 more source

Meisoindigo Acts as a Molecular Glue to Target PKMYT1 for Degradation in Chronic Myeloid Leukemia Therapy

open access: yesAdvanced Science, EarlyView.
Meisoindigo targets PKMYT1 for degradation by acting as a molecular glue that enhances PKMYT1‐TRIM25 interaction, leading to K48‐linked ubiquitination and subsequent proteasomal degradation, thereby exerting therapeutic effects in chronic myeloid leukemia.
Zhao‐Xin Zhang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy